GlassScriptPhysician profile
William F Baker
NPI 1720040793
$9,341.13
in general payments reported to CMS, 2019-2025
43 companies · $1,482 in 2025
The $1,482 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,669 · 2020: $437 · 2021: $1,345 · 2022: $1,684 · 2023: $1,635 · 2024: $1,089 · 2025: $1,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,204.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,960.76 | 2019-2025 | Repatha, Otezla, Evenity |
| Glaxosmithkline, LLC. | $1,099.30 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $799.25 | 2021-2025 | Qulipta, Ubrelvy |
| Janssen Pharmaceuticals, INC | $643.15 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $543.23 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $508.14 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $414.75 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $376.47 | 2019-2025 | Verquvo, Belsomra, Steglatro |
| Radius Health, INC. | $286.38 | 2019-2025 | |
| Novo Nordisk INC | $254.09 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $202.26 | 2021-2025 | |
| Heartflow, INC. | $190.75 | 2025 | |
| Philips North America LLC | $170.02 | 2019-2022 | |
| Daiichi Sankyo INC. | $157.92 | 2019-2024 | Injectafer |
| Lilly USA, LLC | $157.04 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.53 | 2019-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $146.28 | 2019-2025 | Xifaxan |
| Abbott Laboratories | $134.60 | 2019-2025 | Cardiomems, Freestyle Libre 3 |
| Nevro Corp. | $115.74 | 2022-2023 | Senza |
| Otsuka America Pharmaceutical, INC. | $110.70 | 2021-2024 | Rexulti |
| Horizon Therapeutics Plc | $109.10 | 2022-2023 | Krystexxa |
| Medtronic, INC. | $101.65 | 2023 | Contour 3d, Intellis Adaptivestim |
| Advanced Respiratory, INC | $101.20 | 2019 | |
| Shield Therapeutics INC | $89.24 | 2023-2025 | Accrufer |
| Teva Pharmaceuticals USA, INC. | $71.04 | 2019-2025 | Uzedy |
| Lundbeck LLC | $45.80 | 2021-2025 | Rexulti |
| Dexcom, INC. | $37.95 | 2022-2023 | Dexcom G6 Transmitter |
| Electromed, INC. | $35.52 | 2022 | |
| Amarin Pharma, INC. | $35.26 | 2020-2021 | |
| Biosense Webster, INC. | $33.15 | 2023 | Qdot Micro Catheter |
| Abiomed | $32.35 | 2025 | |
| Esperion Therapeutics, INC. | $27.41 | 2021 | |
| Baxter Healthcare | $25.01 | 2023 | Hillrom - Life 2000 Ventilation System |
| Vertex Pharmaceuticals Incorporated | $23.64 | 2025 | |
| Pulmonx Corporation | $19.57 | 2023 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Biohaven Pharmaceutical Holding Company LTD. | $17.92 | 2022 | |
| Allergan, INC. | $17.67 | 2020 | |
| Exact Sciences Corporation | $16.67 | 2025 | The Cologuard Plus Collection Kit |
| Ultragenyx Pharmaceutical INC. | $16.47 | 2025 | Dojolvi |
| Takeda Pharmaceuticals U.S.A., INC. | $16.45 | 2019 | |
| Zyla Life Sciences, INC. | $15.78 | 2020 | |
| Boston Scientific Corporation | $13.66 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.